LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $16,447,000 | +56.2% | 59,920 | +17.9% | 1.18% | +55.3% |
| Q2 2018 | $10,529,000 | +425.7% | 50,824 | +319.1% | 0.76% | +404.0% |
| Q1 2018 | $2,003,000 | -12.8% | 12,127 | -67.1% | 0.15% | -1.9% |
| Q2 2014 | $2,297,000 | -68.0% | 36,887 | -65.4% | 0.15% | -68.7% |
| Q1 2014 | $7,178,000 | +28.1% | 106,716 | -17.6% | 0.49% | -13.4% |
| Q3 2013 | $5,604,000 | +238.8% | 129,489 | +192.8% | 0.57% | +181.2% |
| Q2 2013 | $1,654,000 | – | 44,231 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |